Category: Biopharmaceuticals
-
Invention for Immunogenic Compositions containing Mycobacterium Tuberculosis Polypeptides
Invented by Steven G. Reed, Rhea N. Coler, Gregory C. Ireton, Sylvie Bertholet, Access to Advanced Health Institute AAHI The market for immunogenic compositions containing Mycobacterium tuberculosis polypeptides is expected to witness significant growth in the coming years. Mycobacterium tuberculosis (MTB) is the bacterium responsible for causing tuberculosis (TB), a highly infectious disease that primarily…
-
Invention for Cyclodextrin based polymers
Invented by Jianjun Cheng, Mark E. Davis, Kay T. Khin, Novartis AG The market for cyclodextrin-based polymers has been steadily growing in recent years, driven by their wide range of applications in various industries. These unique polymers, derived from cyclodextrins, offer exceptional properties that make them highly sought after in sectors such as pharmaceuticals, food…
-
Invention for Antibody Fc Mutants with Ablated Effector Functions
Invented by McCarthy Stephen, Bernard Scallon, William Strohl, Susan Tam, Omid Vafa, Janssen Biotech Inc The market for Antibody Fc Mutants with Ablated Effector Functions is witnessing significant growth in recent years. Antibodies are an essential component of the immune system and play a crucial role in fighting against various diseases. However, the effector functions…
-
Invention for Crystal Forms of?-nicotinamide Mononucleotide
Invented by David J. Livingston, Andrew Carr, Philippe Fernandes, Metrobiotech LLC, Metro International Biotech LLC The market for Crystal Forms of Nicotinamide Mononucleotide (NMN) Nicotinamide Mononucleotide (NMN) is a compound that has gained significant attention in recent years due to its potential anti-aging properties. As a precursor to nicotinamide adenine dinucleotide (NAD+), NMN has been…
-
AI in Drafting Biotech and Pharmaceutical Patents
Introduction In the fast-paced world of biotechnology and pharmaceuticals, innovation is the driving force behind groundbreaking discoveries. Protecting these innovations through patents is crucial, but the process of drafting patents in these industries can be exceptionally complex. This is where Artificial Intelligence (AI) is revolutionizing the field. In this comprehensive guide, we will explore how…
-
Invention for Methods of treatment for metabolic reprogramming disorders and compositions
Invented by Barbara Slusher, Jonathan Powell, Institute of Organic Chemistry and Biochemistry CAS, Johns Hopkins University The market for methods of treatment for metabolic reprogramming disorders and compositions is rapidly growing as the understanding of these disorders increases and the demand for effective treatments rises. Metabolic reprogramming disorders refer to a group of conditions that…
-
Invention for Hyperactive Piggybac Transposases
Invented by Eric M. Ostertag, Blair Madison, Poseida Therapeutics Inc The market for hyperactive piggyBac transposases is rapidly expanding as researchers and biotech companies recognize their potential in various fields, including gene therapy, genetic engineering, and drug discovery. PiggyBac transposases are enzymes derived from a mobile genetic element found in insects, and their hyperactive variants…
-
Invention for Fucosylation-deficient cells
Invented by Gang Chen, Darya Burakov, James P. Fandl, Regeneron Pharmaceuticals Inc The market for Fucosylation-deficient cells has been gaining significant attention in recent years. Fucosylation is a process in which fucose, a sugar molecule, is added to proteins or lipids on the cell surface. This modification plays a crucial role in various cellular functions,…
-
Invention for Non-lipidated Variants of Neisseria Meningitidis Orf2086 Antigens
Invented by Annaliesa Sybil Anderson, Kathrin Ute Jansen, Mark Edward Ruppen, Justin Keith Moran, Susan Kay Hoiseth, Wyeth LLC The market for non-lipidated variants of Neisseria Meningitidis Orf2086 antigens is gaining significant attention in the field of vaccine development. Neisseria meningitidis is a bacterium that can cause meningitis and septicemia, leading to severe illness and…
-
Invention for Compositions for treating primary and metastatic neoplastic disease using arsenic compound
Invented by Ralph M. Ellison, Fred H. Mermelstein, PolaRx Biopharmaceuticals Inc The market for compositions for treating primary and metastatic neoplastic disease using arsenic compounds has been steadily growing in recent years. Neoplastic diseases, including primary cancers and metastatic tumors, are a significant global health concern, and finding effective treatments is of utmost importance. Arsenic…